Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
Disclosed herein is a sustained release composition comprising 4-aminopyridine, to improve the neuro-cognitive impairments and related neuro-psychiatric impairments of patients with a demyelinating condition such as multiple sclerosis, traumatic brain injury, cerebral palsy, post-radiation encephalopathy.